Genetic predictors of long-term response and trough levels of infliximab in crohn’s disease
Sara Salvador‐Martín(Unknown), Luis A. López‐Fernández(Spanish Clinical Research Network), Ignacio Marín‐Jiménez(Centro de Investigación Biomédica en Red), Alfredo J. Lucendo(Hospital General de Tomelloso), Elena Lobato(Hospital General Universitario Gregorio Marañón), María Sanjurjo‐Sáez(Hospital General Universitario Gregorio Marañón), Emilio J. Laserna‐Mendieta(Hospital General de Tomelloso), Beatriz López-Cauce(Hospital General Universitario Gregorio Marañón), María I. García(Hospital General Universitario Gregorio Marañón), Judith Abarca‐Zabalía(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Olga Núñez(Hospital General Universitario Gregorio Marañón), Luís Menchén(Universidad Complutense de Madrid)
Cited by 39
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Eosinophilic Esophagitis in Adults Is Associated With IgG4 and Not Mediated by IgE
|Gastroenterology|2014|487
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis
|New England Journal of Medicine|2022|452
Systematic review with meta‐analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population‐based studies
|Alimentary Pharmacology & Therapeutics|2019|309
Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease
|Nature Communications|2020|283